Clinical Trial Update: Efficacy and Safety of Ranibizumab in Two "Treat and Extend" Treatment Algorithms Versus Ranibizumab As Needed in Patients With Macular Edema and Visual Impairment Secondary to Diabetes Mellitus [Phase 3]

View source ↗

Summary

Phase 3 trial comparing two treat-and-extend regimens of ranibizumab versus ranibizumab as-needed in diabetic macular edema; the study has completed and results…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Diabetic Macular Edema

Drugs mentioned

• Lucentis (ranibizumab)

Snippet

Sponsor: Novartis Pharmaceuticals | Conditions: Diabetic Macular Edema | Phase 3 | Status: COMPLETED | Results posted: 2014-09-15